Finanzdaten der Oragenics Inc-Aktie (OGEN)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
14.92%2.59 | 2.26 | 2.50 | 3.12 | 1.71 | |
| Research and Development | 82.29%1.18 | 0.65 | 0.67 | 0.93 | 0.45 |
| Operating Income/Loss | 14.92%-2.59 | -2.26 | -2.50 | -3.12 | -1.71 |
| Nonoperating Income/Loss | 45.59%0.02 | 0.03 | 0.07 | 0.06 | -0.56 |
| Income/Loss From Continuing Operations Before Tax | 15.79%-2.58 | -2.22 | -2.22 | -3.07 | -2.27 |
| Income Tax Expense/Benefit | 104.98%-0.05 | -0.02 | - | - | - |
14.88%-2.53 | -2.20 | -2.29 | -3.07 | -2.27 | |
| Attributable To Parent | 14.88%-2.53 | -2.20 | -2.29 | -3.07 | -2.27 |
| Basic Average Shares | 2.97%4.43 | 4.30 | 18.22 | 1.56 | 0.73 |
| Diluted Average Shares | 2.97%4.43 | 4.30 | 18.22 | 1.56 | 0.73 |
| Basic Earnings Per Share | 11.76%-0.57 | -0.51 | -0.12 | -1.96 | -3.10 |
| Diluted Earnings Per Share | 11.76%-0.57 | -0.51 | -0.12 | -1.96 | -3.10 |